Similarly, 46% of terminal TFs and 30% of terminal metabolic enzymes forming CC-specific TF-metabolic enzyme paths were found to be common with those extracted from breast and ovarian cancer networks (Figures 8H,K). This evidence concerns the gene TF and ovarian cancer.